Outcomes Associated With 3 Treatment Schedules of High-Dose-Rate Brachytherapy Monotherapy for Favorable-Risk Prostate Cancer.

Journal: International journal of radiation oncology, biology, physics
PMID: 26797541

Abstract

PURPOSE: We report the outcomes associated with 3 high-dose-rate (HDR) brachytherapy regimens used as monotherapy for favorable-risk prostate cancer.

Authors

  • Maha Saada Jawad
    Department of Radiation Oncology, Oakland University William Beaumont School of Medicine, Royal Oak, Michigan.
  • Joshua T Dilworth
    Department of Radiation Oncology, Oakland University William Beaumont School of Medicine, Royal Oak, Michigan.
  • Gary S Gustafson
    Department of Radiation Oncology, Oakland University William Beaumont School of Medicine, Royal Oak, Michigan.
  • Hong Ye
    Department of Radiation Oncology, Beaumont Health, Royal Oak, Michigan.
  • Michelle Wallace
    Department of Radiation Oncology, Oakland University William Beaumont School of Medicine, Royal Oak, Michigan.
  • Alvaro Martinez
    MHP Radiation Oncology Institute, 21st Century Oncology, Troy, Michigan.
  • Peter Y Chen
    Department of Radiation Oncology, Oakland University William Beaumont School of Medicine, Royal Oak, Michigan.
  • Daniel J Krauss
    Department of Radiation Oncology, Oakland University William Beaumont School of Medicine, Royal Oak, Michigan. Electronic address: DKrauss@beaumont.edu.

Keywords

External Resources

Popular Topics
Recent Journals